Home › Calculator › RNA Dividend Calculator 2026
RNA Dividend Calculator 2026
No dividendHealthcareAtrium Therapeutics, Inc. · NASDAQ
Price: $8.20 · Annual div: None · Frequency: — · Payout ratio: N/A · Ex-div: —
Calculator settings
RNA is not a dividend-focused stock
RNA pays a very low or no dividend (Yield: 0.00%). This calculator is designed for income-producing assets. If your goal is passive income and compounding, you might want to look at these popular alternatives:
Portfolio growth: DRIP vs No DRIP
Annual dividend income growth
RNA Dividend Yield
Atrium Therapeutics, Inc. (RNA) does not currently pay a regular dividend in our data, so its dividend yield is 0%.
💡 What-if scenarios
Click to apply scenario to the calculator
🎯 When RNA pays your bills
Year your monthly dividend income covers each expense (based on current settings)
About Atrium Therapeutics, Inc. (RNA) — Dividend Analysis 2026
Atrium Therapeutics, Inc. is a biopharmaceutical company dedicated to revolutionizing the treatment of cardiomyopathies by delivering innovative ribonucleic acid (RNA) therapeutics directly to the heart. Their development-stage portfolio currently includes ATR 1072, a siRNA-based therapy targeting the PRKAG2 gene for the treatment of PRKAG2 syndrome, and ATR 1086, another siRNA therapy aimed at the PLN gene to address PLN cardiomyopathy. The company is also actively developing a wider range of pipeline candidates designed to combat various genetic and cardiac diseases. Founded in 2025, Atrium Therapeutics is based in San Diego, California.
RNA Dividend & DRIP — Frequently Asked Questions
Does RNA pay a dividend?
No. Atrium Therapeutics, Inc. (RNA) has not paid a regular dividend in the last 12 months in our data, so its dividend yield is 0% and it produces no dividend income.
How can I get dividend income instead of RNA?
Dividend ETFs such as SCHD, VYM or JEPI pay regular income. Open their DRIP calculators to see what $10,000 would earn per month and how reinvesting grows it.
Does RNA have a DRIP (dividend reinvestment plan)?
A DRIP reinvests dividends into new shares. RNA has no regular dividend in our data, so there is nothing to reinvest.
Stocks similar to RNA
Forward dividend yield from the latest data · open any DRIP calculator
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
Get Your Full RNA DRIP Report by Email
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime. · Privacy Policy
Ready to invest? Open RNA position with:
🌍 RNA Yield by Country & Account Type
Real after-tax yield depends on where you live and how you hold RNA.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| 🇺🇸 Roth IRA / 401k | 0% | 0.00% | -2.80% | $0 / yr |
| 🇺🇸 US Taxable (15%) ✓ | 15% | 0.00% | -2.80% | $0 / yr |
| 🇺🇸 US Taxable (20%) | 20% | 0.00% | -2.80% | $0 / yr |
| 🇬🇧 UK ISA | 0% | 0.00% | -2.80% | $0 / yr |
| 🇬🇧 UK Taxable | 8.75% | 0.00% | -2.80% | $0 / yr |
| 🇨🇦 TFSA | 0% | 0.00% | -2.80% | $0 / yr |
| 🇨🇦 CA Taxable | 25% | 0.00% | -2.80% | $0 / yr |
| 🇦🇺 Super (pension) | 15% | 0.00% | -2.80% | $0 / yr |
| 🇦🇺 AU Taxable | 30% | 0.00% | -2.80% | $0 / yr |
| 🇩🇪 DE Taxable | 26.375% | 0.00% | -2.80% | $0 / yr |
| 🇫🇷 FR Taxable | 30% | 0.00% | -2.80% | $0 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
🎯 RNA Income Goal & Break-Even
12-month CPI (US BLS via FMP economic-indicators).
No dividend data available for this ticker.
Based on current dividend of $0.00/share/yr · 🇺🇸 US Taxable (15%) · static projection (no growth assumed).
📅 RNA Dividend Payment Schedule
RNA pays quarterly — 4 times per year. Ex-div: —.
📊 RNA vs Healthcare Benchmarks
How RNA compares to typical Healthcare averages.
Benchmarks: S&P 500 sector averages (2024–2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for RNA sourced from FMP /financial-growth endpoint — real data, not estimates.
🏛️ RNA Insider Activity
When executives buy their own stock, it's a signal they believe in the dividend's sustainability.
| Insider | Title | Type | Date | Shares | Price | Total Value |
|---|---|---|---|---|---|---|
| F-InKind | 2026-09-18 | 11,216 | $8.95 | $100.4K | ||
| F-InKind | 2026-09-18 | 21,459 | $8.95 | $192.1K | ||
| F-InKind | 2026-09-18 | 22,812 | $8.95 | $204.2K | ||
| F-InKind | 2026-09-18 | 126,418 | $8.95 | $1.13M | ||
| F-InKind | 2026-09-18 | 2,375 | $8.95 | $21.3K | ||
| F-InKind | 2026-09-18 | 11,632 | $8.95 | $104.1K | ||
| F-InKind | 2026-09-18 | 6,742 | $8.95 | $60.3K | ||
| F-InKind | 2026-09-18 | 8,320 | $8.95 | $74.5K |
Insider transactions sourced from SEC Form 4 filings via Financial Modeling Prep. See disclaimer.
Analyst Price Target
Wall Street consensusAnalyst consensus price target via FMP. Not a guarantee of future performance. Past analyst accuracy varies.
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the RNA dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer →
Atrium Therapeutics, Inc. (RNA) is currently trading at $8.20, 51% below its 52-week high. It does not currently pay a regular dividend.
Does RNA Pay a Dividend? Atrium Therapeutics, Inc. Dividend Status
Atrium Therapeutics, Inc. (RNA) is a healthcare stock trading at $8.20. It does not currently pay a regular dividend in our data, so it produces no dividend income and DRIP reinvestment does not apply. Investors seeking income often look at dividend ETFs such as SCHD, VYM or JEPI instead.
- Without a dividend, returns depend entirely on the share price.
Auto-generated from live market data. For educational purposes only — not financial advice.
Latest RNA News
LiveProjected your RNA DRIP returns?
If DividendFlow helped you see your future dividend income clearly, other investors deserve the same clarity. Your review takes 30 seconds and makes a real difference.